July 2, 2021 Journal article Open Access

Alshafie, Walaa; Fotouhi, Maryam; Shlaifer, Irina; Durcan, Thomas M.; McPherson, Peter S.; Laflamme, Carl

JSON-LD (schema.org) Export

{
  "inLanguage": {
    "alternateName": "eng", 
    "@type": "Language", 
    "name": "English"
  }, 
  "description": "<p>Head to head comparison of available commercial antibodies against Serine/threonine-protein kinase TBK1 by immunoblot (Western blot), immunoprecipitation and immunofluorescence.</p>\n\n<p>This work is part of the ALS-Reproducible Antibody Platform (ALS-RAP). ALS-RAP&nbsp;was created as a public-private partnership by three leading ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.</p>", 
  "license": "https://creativecommons.org/licenses/by/4.0/legalcode", 
  "creator": [
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0001-7999-1297", 
      "@type": "Person", 
      "name": "Alshafie, Walaa"
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0001-8937-4719", 
      "@type": "Person", 
      "name": "Fotouhi, Maryam"
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0002-3737-268X", 
      "@type": "Person", 
      "name": "Shlaifer, Irina"
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0003-3942-1956", 
      "@type": "Person", 
      "name": "Durcan, Thomas M."
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0001-7806-5662", 
      "@type": "Person", 
      "name": "McPherson, Peter S."
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0001-5906-025X", 
      "@type": "Person", 
      "name": "Laflamme, Carl"
    }
  ], 
  "headline": "Antibody Characterization Report for Serine/threonine-protein kinase TBK1", 
  "image": "https://zenodo.org/static/img/logos/zenodo-gradient-round.svg", 
  "datePublished": "2021-07-02", 
  "url": "https://zenodo.org/record/5061682", 
  "keywords": [
    "Serine/threonine-protein kinase TBK1", 
    "TBK1", 
    "tbk1", 
    "NF-kappa-B-activating kinase", 
    "T2K", 
    "TANK-binding kinase 1", 
    "NAK", 
    "Q9UHD2", 
    "antibody characterization", 
    "antibody validation", 
    "Amyotrophic lateral sclerosis", 
    "ALS-RAP"
  ], 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.5281/zenodo.5061682", 
  "@id": "https://doi.org/10.5281/zenodo.5061682", 
  "@type": "ScholarlyArticle", 
  "name": "Antibody Characterization Report for Serine/threonine-protein kinase TBK1"
}